FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease
(MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.